All White papers articles – Page 3
-
White papers
Real Estate House View: Europe - First half-year 2024
When is the right time to re-enter the market? Fears of investing whilst values are falling has put significant downwards pressure on investment volumes. Instead, real estate investors have been monitoring government bond yields, seeking stability in the so called ‘risk free rate’ as an indication that property yields have also stabilised. Into 2024, we expect investment activity to pick back up, supporting price discovery. Although the first half-year may only show tentative signs of improvement, by the second we believe activity will regain momentum.
-
White papers
US elections: the Inflation Reduction Act and the risk of repeal
In November the US goes to the polls to decide who will be the next president – the Democrat incumbent Joe Biden or returning Republican nominee Donald Trump. Under Biden, in August 2022 the US introduced the Inflation Reduction Act (IRA), a federal law which aims to, among other things, invest into domestic energy production while promoting clean energy. It represents the largest ever Congressional investment in the energy transition.
-
White papers
Pitchbook: Q&A: Barings BDC’s Freund Says Inbound Deal Activity Strong, Pricing May Tighten
Matt Freund recently shared his thoughts on the current state of the private credit market with PitchBook LCD.
-
White papers
EM Sovereign Debt: Spreads Are Tight… So What?
A superficial look at EM sovereign spreads suggests they may be too tight to offer attractive upside. We disagree, and here’s why.
-
White papers
Four Reasons to Revisit EM Corporate Short Duration Debt
Against a potentially higher-for-longer backdrop, a short-dated approach to EM corporate debt can provide an opportunity to pick up income, incremental yield and diversification, with less volatility.
-
White papers
Are U.S. and European Bonds About to Break Ranks?
The two markets have marched in lockstep for several months, setting up the potential for attractive relative-value and dispersion trades.
-
White papers
The Importance of Active Ownership
Shareholder engagement is for life, not just for proxy-voting season.
-
White papers
Resilience in life sciences: IREI article on the UK versus US life sciences markets
The definition of life sciences real estate - For the purpose of this article, life sciences is defined as an industry that comprises companies involved in the research, development and manufacture of pharmaceuticals, therapies and medical devices, which help to foster medical innovations with the ultimate aim of extending the length and quality of human life. Life sciences real estate is property specifically designed and built for companies within the industry.
-
White papers
Specialty Finance: High-Yielding, Short-Duration and Uncorrelated Private Credit
The underlying assets, bespoke structuring and market dynamics of Specialty Finance can complement a traditional private debt strategy.
-
White papers
Spotting Hidden Extension Risk in Corporate Hybrids
Failure to call a hybrid at the first opportunity is rare but, if realised, can be negative for investors—can we identify the telltale signs of heightened risk?
-
White papers
Private credit: Europe vs the US
The global private credit market is dominated by the US and Europe. M&G believe the European market is set to expand more rapidly. What are the key differences within each region? Which could potentially offer the most attractive risk/return? Our latest insight provides a roadmap for investors.
-
White papers
Emerging markets: From risky to resilient?
A deep dive on emerging markets by Franklin Templeton Fixed Income highlights how emerging markets may be becoming more resilient thanks to higher currency reserves.
-
White papers
EU election results and French politics
The 2024 European Parliament elections took place between 6 and 9 June 2024. The results indicate that the centrist parties should be able to form a working coalition. The European People’s Party (EPP) increased its parliamentary seats. At the same time, parties such as Identity and Democracy (ID) and European Conservatives and Reformists (ECR) with far-right credentials also gained seats.
-
White papers
Absolute Return Overlays: The Power of Diversification on Returns
Expected returns on multi-asset portfolios may be improved materially with the implementation of a portable alpha overlay. Unlike other alternative allocations, portable alpha overlays can be implemented without changing underlying portfolio allocations and/or existing active managers.
-
White papers
Investing in an Interconnected World: Cross-Industry Linkages
Capturing companies’ relationships and interconnections across industries in the course of the investment process can help identify new opportunities and limit portfolio risks.
-
White papers
Why Quant For The Future
In the 1990s PGIM was among the earliest to explore quantitative investment techniques in response to our own clients’ shifting needs. Thirty years and many market cycles later, quants continue to leverage their unique strengths to help investors navigate their complex financial challenges.
-
White papers
Industrial Policy’s Impact: Debt or Dividend
In a race to sharpen their competitive edge, nations are re-deploying industrial policy.
-
White papers
2024 Global Outlook: Changing the Narrative
Dr. Peter Hayes, Global Head of Investment Research, uses the recently published Global Outlook report as a backdrop to discuss how investors should think about constructing a resilient, growth-driven portfolio for the next cycle and why the outlook for 2024 is compelling.
-
White papers
European Industrials: A Hotbed of Growth for Equity Investors
Today’s industrial business models offer surprising sources of consistent earnings growth.
-
White papers
The Healthcare Revolution: A Prescription for Growth
It’s a defining moment for healthcare. From drug discovery to digital delivery, a once-in-a-generation revolution is promising to introduce new cures for some of the most intractable illnesses, as well as personalized treatment at a lower cost.